Received May 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | — | — |
cardiomyopathy; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): 10000556757. A 55-year-old male patient received BNT162b2 (BNT162B2), on 07Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 51 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, single), administration date: 06Jul2021, when the patient was 51-year-old, for COVID-19 immunization; BNT162b2 (Dose 2, single), administration date: 02Aug2021, when the patient was 51-year-old, for COVID-19 immunization. The following information was reported: CARDIOMYOPATHY (death, medically significant), outcome "fatal". Therapeutic measures were taken as a result of cardiomyopathy. The patient date of death was unknown. Reported cause of death: "Cardiomyopathy". It was not reported if an autopsy was performed. Clinical course: On 24Dec2025, it was confirmed the patient died. He added it was related to the Pfizer Covid-19 vaccinations, the patient was warned not to get them, the patient developed Heart trouble (later clarified as pretty significant cardiomyopathy and having stents placed) after his 3rd dose. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Reported Cause(s) of Death: Cardiomyopathy